Cargando…
Unleashing novel horizons in advanced prostate cancer treatment: investigating the potential of prostate specific membrane antigen-targeted nanomedicine-based combination therapy
Prostate cancer (PCa) is a prevalent malignancy with increasing incidence in middle-aged and older men. Despite various treatment options, advanced metastatic PCa remains challenging with poor prognosis and limited effective therapies. Nanomedicine, with its targeted drug delivery capabilities, has...
Autores principales: | He, Mingze, Cao, Yu, Chi, Changliang, Zhao, Jiang, Chong, Eunice, Chin, Ke Xin Casey, Tan, Nicole Zian Vi, Dmitry, Korolev, Yang, Guodong, Yang, Xinyi, Hu, Kebang, Enikeev, Mikhail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545965/ https://www.ncbi.nlm.nih.gov/pubmed/37795091 http://dx.doi.org/10.3389/fimmu.2023.1265751 |
Ejemplares similares
-
Chimeric antigen receptor-modified T cells therapy in prostate cancer: A comprehensive review on the current state and prospects
por: He, Mingze, et al.
Publicado: (2023) -
Research progress on deep learning in magnetic resonance imaging–based diagnosis and treatment of prostate cancer: a review on the current status and perspectives
por: He, Mingze, et al.
Publicado: (2023) -
Unleashing the horizons of labor quality, digitalization on upgradation of industrial structure in Asian economies
por: Zhang, Zujie, et al.
Publicado: (2023) -
The era of prostate-specific membrane antigen for the diagnosis and treatment of prostate cancer: A novel horizon
por: Song, Byeongdo, et al.
Publicado: (2023) -
Therapeutic efficacy of nanomedicines for prostate cancer: An update
por: Lakshmanan, Vinoth-Kumar
Publicado: (2016)